FIG4/SAC3 Antibody
Catalogue Number: ASM10300-A565-ABG
ASM10300-A565 Image
ASM10300-A565 Image
ASM10300-A565 Image
Immunocytochemistry/Immunofluorescence analysis using Mouse Anti-FIG4/SAC3 Monoclonal Antibody, Clone S202-7 (ASM10300). Tissue: Neuroblastoma cell line (SK-N-BE). Species: Human. Fixation: 4% Formaldehyde for 15 min at RT. Primary Antibody: Mouse Anti-FIG4/SAC3 Monoclonal Antibody (ASM10300) at 1:100 for 60 min at RT. Secondary Antibody: Goat Anti-Mouse ATTO 488 at 1:100 for 60 min at RT. Counterstain: Phalloidin Texas Red F-Actin stain; DAPI (blue) nuclear stain at 1:1000; 1:5000 for 60 min RT, 5 min RT. Localization: Cytoplasm, Nucleus, Endosome, Endosome membrane. Magnification: 60X. (A) DAPI (blue) nuclear stain (B) Phalloidin Texas Red F-Actin stain (C) FIG4/SAC3 Antibody (D) Composite.
ASM10300-A565 Image
Western Blot analysis of Mouse Brain Membrane showing detection of ~100 kDa FIG4/SAC3 protein using Mouse Anti-FIG4/SAC3 Monoclonal Antibody, Clone S202-7 (ASM10300). Lane 1: Molecular Weight Ladder. Lane 2: Mouse Brain Membrane. Load: 15 µg. Block: 2% BSA and 2% Skim Milk in 1X TBST. Primary Antibody: Mouse Anti-FIG4/SAC3 Monoclonal Antibody (ASM10300) at 1:200 for 16 hours at 4°C. Secondary Antibody: Goat Anti-Mouse IgG: HRP at 1:1000 for 1 hour RT. Color Development: ECL solution for 6 min in RT. Predicted/Observed Size: ~100 kDa.
| Manufacturer: | Abcepta |
| Type: | Primary Antibody |
| Shipping Condition: | Blue Ice |
| Unit(s): | each |
| Host name: | |
| Clone: | |
| Isotype: | IgG1 |
| Immunogen: | Fusion protein amino acids 688-907 (C-terminus) of mouse Sac3. Rat: 95% identity (203/220 amino acids identical). Human: 91% identity (201/220 amino acids identical) |
| Application: | WB |
Additional Text
Gene Name
FIG4
Purification
Protein G purified
Accession Number
NP_598760.1.
Uniprot ID
Q91WF7
Gene ID
103199
Storage Note
-20C
ASM10300-A565 Datasheet
SUPPORT
outstanding technical support
PRODUCT
we offer a full product guarantee
DELIVERY
we offer free delivery to UK universities and non profit organisations